References
Dutch SPC Sevorane®. (version date 24-5-2005) http://www.cbg-meb.nl/IBteksten/18395.pdf
van Tuijl I, van Vught AJ. Kamertachycardie bij uitleiding uit anesthesie door medicamenteus geïnduceerd verlengd QT-interval. Tijdschr Kindergeneeskd 2003; 71(6): 246–8
Schmeling WT, Warltier DC, McDonald DJ, et al. Prolongation of the QT interval by enflurane, isoflurane, and halothane in humans. Anesth Analg 1991; 72(2): 137–44
Abe K, Takada K, Yoshiya I. Intraoperative torsade de pointes ventricular tachycardia and ventricular fibrillation during sevoflurane anesthesia. Anesth Analg 1998; 86(4): 701–2
Kuenszberg E, Loeckinger A, Kleinsasser A, et al. Sevoflurane progressively prolongs the QT interval in unpremedicated female adults. Eur J Anaesthesiol 2000; 17(11): 662–4
Park WK, Pancrazio JJ, Suh CK, et al. Myocardial depressant effects of sevoflurane. Mechanical and electrophysiologic actions in vitro. Anesthesiology 1996; 84(5): 1166–76
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Groot, M.C.H., van Puijenbroek, E.P. & van Grootheest, A.C. ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006. Drug-Safety 29, 1068 (2006). https://doi.org/10.2165/00002018-200629100-00166
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200629100-00166